In the final episode of 2025 on Antipodes‘ podcast, our sector portfolio managers were tasked with sharing their highest-conviction ideas for the year ahead.
The episodes produces an eclectic mix of stock ideas across global industrials, healthcare, infrastructure, technology, and emerging markets.
But it also underscores a common themes our team believes will reward investors in 2025 – looking for companies that are mispriced relative to their business resilience and growth profile.
Stock commentary is illustrative only, not a recommendation to buy, hold, or sell any security.
Key times:
- 1:00 | Graham Hay – Industrials (Honeywell International Inc)
- 8:30 | Nick Cameron – Healthcare (Merck & Co Inc)
- 17:30 | Max Shramchenko – Infrastructure (Companhia de Saneamento Básico do Estado de São Paulo)
- 26:30 | James Rodda – Technology (Oracle Corp)
- 35:00 | John Stavliotis – Emerging Markets (Globant SA)
You can subscribe to our podcast on Apple or Spotify, to be notified as soon as upcoming episodes are published
Subscribe to receive the latest news and insights from the Antipodes team


